The application of clinical proteomics to cancer and other diseases

Research output: Contribution to journalArticle

Abstract

The term "clinical proteomics" refers to the application of available proteomics technologies to current areas of clinical investigation. The ability to simultaneously and comprehensively examine changes in large numbers of proteins in the context of disease or other changes in physiological conditions holds great promise as a tool to unlock the solutions to difficult clinical research questions. Proteomics is a rapidly growing field that combines high throughput analytical methodologies such as two-dimensional gel electrophoresis and SELDI mass spectrometry methods with complex bioinformatics to study systems biology - the system of interest is defined by the investigator. Even with all its potential, however, studies must be carefully designed in order to differentiate true clinical differences in protein expression from differences originating from variation in sample collection, variation in experimental condition, and normal biological variability. Proteomic analyses are already widely in use for clinical studies ranging from cancer to other diseases such as cardiovascular disease, organ transplant, and pharmacodynamic studies.

Original languageEnglish (US)
Pages (from-to)1562-1570
Number of pages9
JournalClinical Chemistry and Laboratory Medicine
Volume41
Issue number12
DOIs
StatePublished - 2003

Fingerprint

Proteomics
Neoplasms
Pharmacodynamics
Transplants
Systems Biology
Electrophoresis, Gel, Two-Dimensional
Bioinformatics
Computational Biology
Electrophoresis
Mass spectrometry
Mass Spectrometry
Proteins
Cardiovascular Diseases
Gels
Research Personnel
Throughput
Technology
Research

Keywords

  • 2-D Gel electrophoresis
  • Cancer proteomics
  • Clinical proteomics
  • Mass spectrometry

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

@article{63ac60fd50ec4d82924f370b311eb31e,
title = "The application of clinical proteomics to cancer and other diseases",
abstract = "The term {"}clinical proteomics{"} refers to the application of available proteomics technologies to current areas of clinical investigation. The ability to simultaneously and comprehensively examine changes in large numbers of proteins in the context of disease or other changes in physiological conditions holds great promise as a tool to unlock the solutions to difficult clinical research questions. Proteomics is a rapidly growing field that combines high throughput analytical methodologies such as two-dimensional gel electrophoresis and SELDI mass spectrometry methods with complex bioinformatics to study systems biology - the system of interest is defined by the investigator. Even with all its potential, however, studies must be carefully designed in order to differentiate true clinical differences in protein expression from differences originating from variation in sample collection, variation in experimental condition, and normal biological variability. Proteomic analyses are already widely in use for clinical studies ranging from cancer to other diseases such as cardiovascular disease, organ transplant, and pharmacodynamic studies.",
keywords = "2-D Gel electrophoresis, Cancer proteomics, Clinical proteomics, Mass spectrometry",
author = "William Clarke and Zhen Zhang and Chan, {Daniel Wan-Yui}",
year = "2003",
doi = "10.1515/CCLM.2003.239",
language = "English (US)",
volume = "41",
pages = "1562--1570",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "12",

}

TY - JOUR

T1 - The application of clinical proteomics to cancer and other diseases

AU - Clarke, William

AU - Zhang, Zhen

AU - Chan, Daniel Wan-Yui

PY - 2003

Y1 - 2003

N2 - The term "clinical proteomics" refers to the application of available proteomics technologies to current areas of clinical investigation. The ability to simultaneously and comprehensively examine changes in large numbers of proteins in the context of disease or other changes in physiological conditions holds great promise as a tool to unlock the solutions to difficult clinical research questions. Proteomics is a rapidly growing field that combines high throughput analytical methodologies such as two-dimensional gel electrophoresis and SELDI mass spectrometry methods with complex bioinformatics to study systems biology - the system of interest is defined by the investigator. Even with all its potential, however, studies must be carefully designed in order to differentiate true clinical differences in protein expression from differences originating from variation in sample collection, variation in experimental condition, and normal biological variability. Proteomic analyses are already widely in use for clinical studies ranging from cancer to other diseases such as cardiovascular disease, organ transplant, and pharmacodynamic studies.

AB - The term "clinical proteomics" refers to the application of available proteomics technologies to current areas of clinical investigation. The ability to simultaneously and comprehensively examine changes in large numbers of proteins in the context of disease or other changes in physiological conditions holds great promise as a tool to unlock the solutions to difficult clinical research questions. Proteomics is a rapidly growing field that combines high throughput analytical methodologies such as two-dimensional gel electrophoresis and SELDI mass spectrometry methods with complex bioinformatics to study systems biology - the system of interest is defined by the investigator. Even with all its potential, however, studies must be carefully designed in order to differentiate true clinical differences in protein expression from differences originating from variation in sample collection, variation in experimental condition, and normal biological variability. Proteomic analyses are already widely in use for clinical studies ranging from cancer to other diseases such as cardiovascular disease, organ transplant, and pharmacodynamic studies.

KW - 2-D Gel electrophoresis

KW - Cancer proteomics

KW - Clinical proteomics

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=0346097940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346097940&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2003.239

DO - 10.1515/CCLM.2003.239

M3 - Article

C2 - 14708880

AN - SCOPUS:0346097940

VL - 41

SP - 1562

EP - 1570

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 12

ER -